MARÍA PILAR GARCÍA ALFONSO-rekin lankidetzan egindako argitalpenak (8)

2009

  1. Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: A phase II study of the Spanish GOTI group

    British Journal of Cancer, Vol. 101, Núm. 7, pp. 1039-1043

  2. Tratamiento con fulvestrant en mujeres posmenopáusicas con cáncer de mama avanzado tras tratamiento hormonal previo

    Medicina Clinica, Vol. 133, Núm. 10, pp. 371-374

2006

  1. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

    Annals of Oncology, Vol. 17, Núm. 7, pp. 1103-1110

2004

  1. Weekly irinotecan (CPT-11) in 5-FU heavily pretreated and poor-performance-status patients with advanced colorectal cancer

    Medical Oncology, Vol. 21, Núm. 3, pp. 255-262

2002

  1. Tratamiento con quimioterapia del cáncer de mama metastásico

    Revisiones en Cancer, Vol. 16, Núm. 4, pp. 172-184

1998

  1. Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: Results from a prospective, multicenter trial with double randomization

    Journal of Clinical Oncology, Vol. 16, Núm. 4, pp. 1538-1546

1991

  1. Male breast cancer: revision of 49 patients

    Oncologia, Vol. 14, Núm. 2, pp. 68-72

  2. The treatment of advanced and metastatic colorectal cancer. Experience of the Oncology Department of the General Hospital Gregorio Maranon in Madrid

    Oncologia